^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    ALA-101

    i
    Other names: ALA-101, CD19-directed CAR-iNKT, CAR19-iNKT
    Associations
    News
    Trials
    Company:
    Arovella Therap, Imperial College London
    Drug class:
    CD19 inhibitor, iNKT agonist
    Related drugs:
    Associations
    News
    Trials